Viral RNA was extracted from 200 to 500 μL of plasma using the High Pure Viral RNA Kit (Roche Diagnostics Systems, Basel, Switzerland) or the Nuclisense EasyMag (BioMérieux, Durham, NC, USA). DNA was extracted from a 200-μL suspension of PBMCs or buffy coat cells with the Qiagen Whole Blood Extraction Kit see more (Qiagen, Hilden, Germany) or Nuclisense EasyMag. All extractions were performed according to the manufacturers’ instructions. Ficoll-Hypaque density-purified PBMCs (107 cells) were used immediately after isolation for co-cultivation with 5 × 106 phytohaemagglutinin-stimulated donor PBMCs in RPMI-1640 medium supplemented with interleukin-2

as described previously [13]. Cultures were considered positive when two consecutive p24 antigen determinations revealed the presence of the viral antigen, after which the supernatant was harvested. One mL of the supernatant was transferred to a 5-mL suspension of MT2 cells [14]. Cells were checked visually for the presence of syncytia every 2 days. p24 antigen determination was performed on days 5, 10 and 20. The culture was stopped and the

isolate considered MT2 negative when the p24 antigen determination was negative and syncytia remained absent Vemurafenib order at day 20. Plasma HIV-1 RNA was quantified with the Amplicor HIV Monitor v1.5 test (Roche Diagnostics Systems), with a lower limit of detection of 50 RNA copies/mL, or the Abbott RealTime HIV-1 assay (Abbott Molecular Inc., Des Plaines, IL, USA), with a lower detection limit of 40 RNA copies/mL. The CD4 cell count was determined for the fresh blood sample by flow cytometry (using a FACScan cytofluorometer and cellquest software; Gefitinib Beckton Dickinson, Mountain View, CA, USA). Absolute CD4 cell counts were expressed per μL of blood. Amplification of a fragment spanning the V1 to V4 region of the HIV-1 env gene was performed using the Titan One Tube RT-PCR system (Roche), for both

RNA and DNA amplification. For DNA amplification, the RT step was omitted from the thermal cycling programme. A nested polymerase chain reaction (PCR) amplification protocol was used with the outer primers 6540 (HXB2 nucleotide positions 6540–6560; forward primer) and 7701 (positions 7701–7721; reverse primer) and inner primers 6561 (positions 6561–6580; forward primer) and 7645 (positions 7645–7667; reverse primer). Sequencing reactions were run with the BigDye® Terminator Cycle Sequencing kit v. 3.1 (Applied Biosystems, Life Technologies, Carlsbad, CA, USA) and three degenerate internal primers: 5′-AGYRCAGTACAATGYACACATGG-3′ (forward primer 1), 5′-TCAACHCAAYTRCTGTTAAATGG-3′ (forward primer 2) and 5′-ATTACARTAGAAAAATTCYCCTCYAC-3′ (reverse primer).